ARCHIVES

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013

Grants Awarded To Combat Tobacco In Developing Countries

October 4, 2002

Community Center Group To Consider “Clinical Standards, Medical Audit”

September 13, 1974

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

Information Branches Combined Under ICIC, Moved to Office Of NCI Deputy Director

November 23, 1997

In Brief: Diane Fink Moves to ACS California Div.; Preisler Names Director Of Cancer Center In Cincinnati

February 10, 1989